Abstract
In recent years, phytochemicals have emerged as potential therapeutic agents against various diseases such as diabetes, microbial infections and cancer due to their minimum side effects and low cost. Plant-derived molecules improve disease conditions either directly or indirectly via targeting disease-causing factors or boosting the immune system. The immunomodulatory actions of phytochemicals play a vital role in the improvement of diabetes, microbial diseases, and cancer. Further, immunomodulatory properties of phytochemicals have been observed in tumor-bearing hosts. Therefore, phytochemicals with immunomodulatory properties are emerging as immunotherapeutic agents against cancer. The present book chapter discusses the in vitro immunomodulatory properties of phytochemicals against tumor-associated immune cells and associated mechanisms.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Adeonipekun PA, Adeniyi TA, David ED. Antimicrobial properties and melissopalynology, proximate and elemental analyses of honey samples from three different ecozones in Nigeria. Notulae Sci Biol. 2016;8(3):326–33. https://doi.org/10.15835/nsb839844.
Bae JH, Kim JY, Kim MJ, Chang SH, Park YS, Son CH, Park SJ, Chung JS, Lee EY, Kim SH, Kang CD. Quercetin enhances susceptibility to NK cell-mediated lysis of tumor cells through induction of NKG2D ligands and suppression of HSP70. J Immunother. 2010;33:391–401. https://doi.org/10.1097/CJI.0b013e3181d32f22.
Balsamo M, Vermi W, Parodi M, Pietra G, Manzini C, Queirolo P, Lonardi S, Augugliaro R, Moretta A, Facchetti F, Moretta L, Mingari MC, Vitale M. Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor. Eur J Immunol. 2012;42(7):1833–42. https://doi.org/10.1002/eji.201142179.
Bhattacharyya S, Mandal D, Saha B, Sen GS, Das T, Sa G. Curcumin prevents tumor-induced T cell apoptosis through Stat-5a-mediated Bcl-2 induction. J Biol Chem. 2007;282(22):15954–64. https://doi.org/10.1074/jbc.M608189200.
Bhattacharyya S, Md Sakib Hossain D, Mohanty S, Sankar Sen G, Chattopadhyay S, Banerjee S, Chakraborty J, Das K, Sarkar D, Das T, Sa G. Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts. Cell Mol Immunol. 2010;7(4):306–15. https://doi.org/10.1038/cmi.2010.11.
Bhaumik S, Jyothi MD, Khar A. Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells. FEBS Lett. 2000;483(1):78–82. https://doi.org/10.1016/S0014-5793(00)02089-5.
Bill MA, Bakan C, Benson DM Jr, Fuchs J, Young G, Lesinski GB. Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines. Mol Cancer Ther. 2009;8(9):2726–35. https://doi.org/10.1158/1535-7163.MCT-09-0377.
Brouet I, Ohshima H. Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun. 1995;206(2):533–40. https://doi.org/10.1006/bbrc.1995.1076.
Burkard M, Leischner C, Lauer UM, Busch C, Venturelli S, Frank J. Dietary flavonoids and modulation of natural killer cells: implications in malignant and viral diseases. J Nutr Biochem. 2017;46:1–12. https://doi.org/10.1016/j.jnutbio.2017.01.006.
Carrero P, Ortega H, Martinez-Botas J, Gomez-Coronado D, Lasuncion MA. Flavonoid-induced ability of minimally modified low-density lipoproteins to support lymphocyte proliferation. Biochem Pharmacol. 1998;55(7):1125–9. https://doi.org/10.1016/S0006-2952(97)00635-7.
Caspi RR. Immunotherapy of autoimmunity and cancer: the penalty for success. Nat Rev Immunol. 2008;8(12):970–6. https://doi.org/10.1038/nri2438.
Chaplin DD. Overview of the immune response. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S3–23. https://doi.org/10.1016/j.jaci.2009.12.980.
Chen D, Nie M, Fan MW, Bian Z. Anti-inflammatory activity of curcumin in macrophages stimulated by lipopolysaccharides from Porphyromonas gingivalis. Pharmacology. 2008;82(4):264–9. https://doi.org/10.1159/000161127.
Chew V, Toh HC, Abastado JP. Immune microenvironment in tumor progression: characteristics and challenges for therapy. J Oncol. 2012;2012:608406. https://doi.org/10.1155/2012/608406.
Corthay A. How do regulatory T cells work? Scand J Immunol. 2009;70(4):326–36. https://doi.org/10.1111/j.1365-3083.2009.02308.x.
Cundell RD. Herbal phytochemicals as immunomodulators. Curr Immunol Rev. 2014;10(2):64–81. https://doi.org/10.2174/1573395510666140915213156.
Dahlberg CI, Sarhan D, Chrobok M, Duru AD, Alici E. Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity. Front. Immunol. 2015;6:605. https://doi.org/10.3389/fimmu.2015.00605.
Devaud C, John LB, Westwood JA, Darcy PK, Kershaw MH. Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy. Oncoimmunology. 2013;2(8):e25961. https://doi.org/10.4161/onci.25961.
Driessens G, Kline J, Gajewski TF. Costimulatory and coinhibitory receptors in anti-tumor immunity. Immunol Rev. 2009;229(1):126–44. https://doi.org/10.1111/j.1600-065X.2009.00771.x.
Espinoza JL, Nguyen VH, Ichimura H, Pham TT, Nguyen CH, Pham TV, Elbadry MI, Yoshioka K, Tanaka J, Trung LQ, Takami A, Nakao S. A functional polymorphism in the NKG2D gene modulates NK-cell cytotoxicity and is associated with susceptibility to Human Papilloma Virus-related cancers. Sci Rep. 2016;6:39231. https://doi.org/10.1038/srep39231.
Falchetti R, Fuggetta MP, Lanzilli G, Tricarico M, Ravagnan G. Effects of resveratrol on human immune cell function. Life Sci. 2001;70(1):81–96. https://doi.org/10.1016/S0024-3205(01)01367-4.
Fiala M. Curcumin and omega-3 fatty acids enhance NK cell-induced apoptosis of pancreatic cancer cells but curcumin inhibits interferon-gamma production: benefits of omega-3 with curcumin against cancer. Molecules. 2015;20(2):3020–6. https://doi.org/10.3390/molecules20023020.
Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 2013;14(10):1014–22. https://doi.org/10.1038/ni.2703.
Gao S, Zhou J, Liu N, Wang L, Gao Q, Wu Y, Zhao Q, Liu P, Wang S, Liu Y, Guo N, Shen Y, Yuan Z. Curcumin induces M2 macrophage polarization by secretion IL-4 and/or IL-13. J Mol Cell Cardiol. 2015;85:131–9. https://doi.org/10.1016/j.yjmcc.2015.04.025.
Giurisato E, Xu Q, Lonardi S, Telfer B, Russo I, Pearson A, Finegan KG, Wang W, Wang J, Gray NS, Vermi W, **a Z, Tournier C. Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition. Proc Natl Acad Sci U S A. 2018;115(12):E2801–10. https://doi.org/10.1073/pnas.1707929115.
Guillerey C, Huntington ND, Smyth MJ. Targeting natural killer cells in cancer immunotherapy. Nat Immunol. 2016;17(9):1025–36. https://doi.org/10.1038/ni.3518.
Halder RC, Almasi A, Sagong B, Leung J, Jewett A, Fiala M. Curcuminoids and omega-3 fatty acids with anti-oxidants potentiate cytotoxicity of natural killer cells against pancreatic ductal adenocarcinoma cells and inhibit interferon gamma production. Front Physiol. 2015;6:129. https://doi.org/10.3389/fphys.2015.00129.
Han R, Wu WQ, Wu XP, Liu CY. Effect of total flavonoids from the seeds of Astragali complanati on natural killer cell function. J Ethnopharmacol. 2015;173:157–65. https://doi.org/10.1016/j.jep.2015.07.017.
Her M, Kavanaugh A. Alterations in immune function with biologic therapies for autoimmune disease. J Allergy Clin Immunol. 2016;137(1):19–27. https://doi.org/10.1016/j.jaci.2015.10.023.
Hou D, Wang D, Ma X, Chen W, Guo S, Guan H. Effects of total flavonoids of sea buckthorn (Hippophae rhamnoides L.) on cytotoxicity of NK92-MI cells. Int J Immunopathol Pharmacol. 2017;30(4):353–61. https://doi.org/10.1177/0394632017736673.
Kim HP, Son KH, Chang HW, Kang SS. Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci. 2004; 96(3):229–45.
Kliem C, Merling A, Giaisi M, Kohler R, Krammer PH, Li-Weber M. Curcumin suppresses T cell activation by blocking Ca2+ mobilization and nuclear factor of activated T cells (NFAT) activation. J Biol Chem. 2012;287(13):10200–9. https://doi.org/10.1074/jbc.M111.318733.
Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an overview. Sci World J. 2013;2013:162750. https://doi.org/10.1155/2013/162750.
Langers I, Renoux VM, Thiry M, Delvenne P, Jacobs N. Natural killer cells: role in local tumor growth and metastasis. Biologics: Targets Ther. 2012;6:73–82. https://doi.org/10.2147/BTT.S23976.
Lee HH, Cho H. Improved anti-cancer effect of curcumin on breast cancer cells by increasing the activity of natural killer cells. J Microbiol Biotechnol. 2018;28(6):874–82. https://doi.org/10.4014/jmb.1801.01074.
Lee JK, Kim SY, Kim YS, Lee WH, Hwang DH, Lee JY. Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin. Biochem Pharmacol. 2009;77(8):1391–400. https://doi.org/10.1016/j.bcp.2009.01.009.
Leiro J, Alvarez E, Garcia D, Orallo F. Resveratrol modulates rat macrophage functions. Int Immunopharmacol. 2002;2(6):767–74. https://doi.org/10.1016/S1567-5769(02)00014-0.
Li Q, Huyan T, Ye LJ, Li J, Shi JL, Huang QS. Concentration-dependent biphasic effects of resveratrol on human natural killer cells in vitro. J Agric Food Chem. 2014;62(45):10928–35. https://doi.org/10.1021/jf502950u.
Lopez-Posadas R, Ballester I, Abadia-Molina AC, Suarez MD, Zarzuelo A, Martinez-Augustin O, Sanchez de Medina F. Effect of flavonoids on rat splenocytes, a structure-activity relationship study. Biochem Pharmacol. 2008;76(4):495–506. https://doi.org/10.1016/j.bcp.2008.06.001.
Lu CC, Chen JK. Resveratrol enhances perforin expression and NK cell cytotoxicity through NKG2D-dependent pathways. J Cell Physiol. 2010;223(2):343–51. https://doi.org/10.1002/jcp.22043.
Mandal A, Viswanathan C. Natural killer cells: in health and disease. Hematol Oncol Stem Cell Ther. 2015;8(2):47–55. https://doi.org/10.1016/j.hemonc.2014.11.006.
Murr C, Schroecksnadel K, Winkler C, Ledochowski M, Fuchs D. Antioxidants may increase the probability of develo** allergic diseases and asthma. Med Hypotheses. 2005;64(5):973–7. https://doi.org/10.1016/j.mehy.2004.11.011.
Nagendran J, Bleackley C, Ross DB, West LJ, Dyck JR. Resveratrol attenuates stimulated t-cells activation and proliferation: a novel therapy against cellular rejection in cardiac transplantation. J Heart Lung Transplant. 2013;32(4S):S248–9. https://doi.org/10.1016/j.healun.2013.01.642.
Nair MP, Mahajan S, Reynolds JL, Aalinkeel R, Nair H, Schwartz SA, Kandaswami C. The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system. Clin Vaccine Immunol. 2006;13(3):319–28. https://doi.org/10.1128/CVI.13.3.319-328.2006.
Nielsen SR, Schmid MC. Macrophages as key drivers of cancer progression and metastasis. Mediat Inflamm. 2017;2017:9624760. https://doi.org/10.1155/2017/9624760.
Panche AN, Diwan AD, Chandra SR. Flavonoids: an overview. J Nutr Sci. 2016;5:e47. https://doi.org/10.1017/jns.2016.41.
Richards DM, Hettinger J, Feuerer M. Monocytes and macrophages in cancer: development and functions. Cancer Microenviron. 2013;6(2):179–91. https://doi.org/10.1007/s12307-012-0123-x.
Roszer T. Understanding the mysterious M2 macrophage through activation markers and effector mechanisms. Mediat Inflamm. 2015;2015:816460. https://doi.org/10.1155/2015/816460.
Schwager J, Richard N, Widmer F, Raederstorff D. Resveratrol distinctively modulates the inflammatory profiles of immune and endothelial cells. BMC Complement Altern Med. 2017;17(1):309. https://doi.org/10.1186/s12906-017-1823-z.
Seager RJ, Hajal C, Spill F, Kamm RD, Zaman MH. Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression. Converg Sci Phys Oncol. 2017;3:034002. https://doi.org/10.1088/2057-1739/aa7e86.
Shukla S, Mehta A. Comparative phytochemical analysis and in vivo immunomodulatory activity of various extracts of Stevia rebaudiana leaves in experimental animal model. Front Life Sci. 2014;8(1):55–63. https://doi.org/10.1080/21553769.2014.961615.
Sithranga Boopathy N, Kathiresan K. Anticancer drugs from marine flora: an overview. J Oncol. 2010;2010:214186. https://doi.org/10.1155/2010/214186.
Smith HA, Kang Y. The metastasis-promoting roles of tumor-associated immune cells. J Mol Med (Berl). 2013;91(4):411–29. https://doi.org/10.1007/s00109-013-1021-5.
Sun L, Chen B, Jiang R, Li J, Wang B. Resveratrol inhibits lung cancer growth by suppressing M2-like polarization of tumor associated macrophages. Cell Immunol. 2017;311:86–93. https://doi.org/10.1016/j.cellimm.2016.11.002.
Sungur CM, Murphy WJ. Positive and negative regulation by NK cells in cancer. Crit Rev Oncog. 2014;19(1–2):57–66. https://doi.org/10.1615/CritRevOncog.2014010805.
Verbeek R, Plomp AC, van Tol EA, van Noort JM. The flavones luteolin and apigenin inhibit in vitro antigen-specific proliferation and interferon-gamma production by murine and human autoimmune T cells. Biochem Pharmacol. 2004;68(4):621–9. https://doi.org/10.1016/j.bcp.2004.05.012.
Waldhauer I, Steinle A. NK cells and cancer immunosurveillance. Oncogene. 2008;27(45):5932–43. https://doi.org/10.1038/onc.2008.267.
Watson JL, Vicario M, Wang A, Moreto M, McKay DM. Immune cell activation and subsequent epithelial dysfunction by Staphylococcus enterotoxin B is attenuated by the green tea polyphenol (-)-epigallocatechin gallate. Cell Immunol. 2005;237(1):7–16. https://doi.org/10.1016/j.cellimm.2005.08.030.
Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008;27(45):5904–12. https://doi.org/10.1038/onc.2008.271.
Wolowczuk I, Verwaerde C, Viltart O, Delanoye A, Delacre M, Pot B, Grangette C. Feeding our immune system: impact on metabolism. Clin Dev Immunol. 2008;2008:639803. https://doi.org/10.1155/2008/639803.
Wong GK, Heather JM, Barmettler S, Cobbold M. Immune dysregulation in immunodeficiency disorders: the role of T-cell receptor sequencing. J Autoimmun. 2017;80:1–9. https://doi.org/10.1016/j.jaut.2017.04.002.
Wu J, Lanier LL. Natural killer cells and cancer. Adv Cancer Res. 2003;90:127–56. https://doi.org/10.1016/S0065-230X(03)90004-2.
Yang L, Zhang Y. Tumor-associated macrophages: from basic research to clinical application. J Hematol Oncol. 2017;10(1):58. https://doi.org/10.1186/s13045-017-0430-2.
Yang Y, Paik JH, Cho D, Cho JA, Kim CW. Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells. Int Immunopharmacol. 2008;8(4):542–7. https://doi.org/10.1016/j.intimp.2007.12.006.
Yuan Y, Jiang YC, Sun CK, Chen QM. Role of the tumor microenvironment in tumor progression and the clinical applications (review). Oncol Rep. 2016;35:2499–515. https://doi.org/10.3892/or.2016.4660.
Zamai L, Ahmad M, Bennett IM, Azzoni L, Alnemri ES, Perussia B. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J Exp Med. 1998;188(12):2375–80. https://doi.org/10.1084/jem.188.12.2375.
Zhao GJ, Lu ZQ, Tang LM, Wu ZS, Wang DW, Zheng JY, Qiu QM. Curcumin inhibits suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro. Int Immunopharmacol. 2012;14(1):99–106. https://doi.org/10.1016/j.intimp.2012.06.016.
Zhou Y, Zhang T, Wang X, Wei X, Chen Y, Guo L, Zhang J, Wang C. Curcumin modulates macrophage polarization through the inhibition of the toll-like receptor 4 expression and its signaling pathways. Cell Physiol Biochem. 2015;36(2):631–41. https://doi.org/10.1159/000430126.
Zou T, Yang Y, **a F, Huang A, Gao X, Fang D, **ong S, Zhang J. Resveratrol inhibits CD4+ T cell activation by enhancing the expression and activity of Sirt1. PLoS One. 2013;8(9):e75139. https://doi.org/10.1371/journal.pone.0075139.
Zou JY, Su CH, Luo HH, Lei YY, Zeng B, Zhu HS, Chen ZG. Curcumin converts Foxp3+ regulatory T cells to T helper 1 cells in patients with lung cancer. J Cell Biochem. 2018;119(2):1420–8. https://doi.org/10.1002/jcb.26302.
Acknowledgement
We thankfully acknowledge fellowship support to Pradip Kumar Jaiswara [Award No. 1002/(SC)(CSIR-UGC NET DEC. 2016] and Shiv Govind Rawat [Award No. 09/013(0772/2018-EMR-I)] from CSIR, New Delhi and Pratishtha Sonker [Award No. F117.1/201516/RGNF201517SCUTT4822/(SAIII/Website)] from UGC, New Delhi. Funding from University Grants Commission and Department of Science & Technology, New Delhi, India, in the form of UGC-Start-Up Research (F. No. 30-370/2017 (BSR)) and Early Career Research Award (ECR/2016/001117) is highly acknowledged. Financial support from ISLS and UGC-UPE, Banaras Hindu University is also acknowledged. We also acknowledge UGC-CAS and DST-FIST program to the Department of Zoology, Banaras Hindu University, India.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Jaiswara, P.K., Gupta, V.K., Rawat, S.G., Sonker, P., Kumar, A. (2019). Reprogramming of Tumor Associated Immune Cells by Phytochemicals: In-vitro Approaches for Cancer Treatment. In: Kumar, S., Egbuna, C. (eds) Phytochemistry: An in-silico and in-vitro Update. Springer, Singapore. https://doi.org/10.1007/978-981-13-6920-9_4
Download citation
DOI: https://doi.org/10.1007/978-981-13-6920-9_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-6919-3
Online ISBN: 978-981-13-6920-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)